title: [Cross-sectional imaging of peripheral involvement in psoriatic arthritis].
abstract: The purpose of this article is to: 1) describe the main plain film, ultrasound and MR imaging features of peripheral involvement in psoriatic arthritis, 2) describe the advantages of ultrasound and MRI at the early stages of the disease; 3) describe how to use MRI and ultrasound in order to assess response to tumor necrosis factor-alpha blocker therapy.
authors.affiliation: Service de Radiologie Centrale, CHU Purpan, 31059 Toulouse cedex, France. denis_a@chu-toulouse.fr
authors.forename: A
authors.initials: A
authors.lastname: Denis
authors.forename: F
authors.initials: F
authors.lastname: Lapegue
authors.forename: N
authors.initials: N
authors.lastname: Sans
authors.forename: J
authors.initials: J
authors.lastname: Vial
authors.forename: H
authors.initials: H
authors.lastname: Chiavassa-Gandois
authors.forename: B
authors.initials: B
authors.lastname: Fournie
authors.forename: J J
authors.initials: JJ
authors.lastname: Railhac
mesh_terms: D000173:Acromioclavicular Joint / Q000473:pathology; D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005384:Finger Joint / Q000473:pathology; D005500:Follow-Up Studies; D006621:Hip Joint / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D012785:Shoulder Joint / Q000473:pathology; D013585:Synovitis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014463:Ultrasonography; D018615:Ultrasonography, Doppler, Color
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha